Suptavumab: A Deep Dive into the REGN2222 Monoclonal Antibody Suptavumab is a monoclonal protein designed to precisely bind IL18, a key cytokine associated in significant respiratory failure syndrome https://www.targetmol.com/compound/suptavumab